HomeNewsEconomyPolicyExplained | Why does India need a new public-private partnership policy?

Explained | Why does India need a new public-private partnership policy?

Public-Private Partnership has a mixed track record of failures and successes but the government is confident about it, given its success in airports, railways and many highways, and wants a new policy that will facilitate private investment.

June 29, 2021 / 16:35 IST
Story continues below Advertisement
Union Finance Minister Nirmala Sitharaman
Union Finance Minister Nirmala Sitharaman

The central government announced on June 28 that it would formulate a new public-private partnership (PPP) policy to improve the ease of doing business by cutting red tape and reduce the number of clearances.

In the 2021-22 Budget speech, Finance Minister Nirmala Sitharaman had announced that monetising operating public infrastructure assets is a very important financing option for new construction.

Story continues below Advertisement

The PPP model has delivered mixed results in India on account of overextended balance sheets, contract disputes, land acquisition problems, and lack of a dispute-resolution mechanism.

However, the government is extremely confident about the PPP model because of its success in the airports, roads, and railway sectors.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show